Earnings call transcript: REX American Resources Q1 2026 sees record EPS, stock dips

REX American Resources delivered a record Q1 2026 EPS of $0.56, far above the $0.14 consensus and up 115% year over year, but revenue missed at $156.5 million versus $167.23 million expected. Gross profit rose to $29.1 million and the company ended with $364.3 million in cash and no bank debt, though shares fell 0.37% pre-market on the revenue miss. Management reaffirmed progress on the Gibson City ethanol expansion and carbon capture projects, while regulatory timing remains a key watch item.

Analysis

The market is likely underappreciating the quality of this earnings beat because it is being misread through a top-line lens. For a commodity processor, the real signal is that margin capture is improving even as absolute revenue lags, which usually means the company is benefiting from a better input/output spread and/or monetizing policy credits more effectively than peers. That tends to be a more durable driver than one-quarter revenue outperformance, especially when balance sheet optionality is intact.

The second-order winner is not just REX, but any ethanol-linked name with exposure to Section 45Z and low-cost assets; the policy credit effectively widens the moat between well-capitalized operators and smaller plants that cannot fund compliance, expansion, or permitting. If the credit regime holds, the competitive set should compress over the next 2-4 quarters as weaker producers lose pricing discipline or sell assets, supporting spreads for the best-positioned operators. Conversely, if the regulatory framework gets delayed or narrowed, the earnings power here could mean-revert quickly because a meaningful share of the current profitability is policy-assisted rather than purely cyclical.

The key catalyst path is asymmetrical: near-term shares may stay capped because investors want to see revenue acceleration and clarity on permits, but the medium-term setup improves if the expansion stays on schedule into late 2026. The biggest tail risk is a policy stumble at either the federal tax-credit level or the Illinois permitting timeline, which would likely hit sentiment before cash flow because the stock is already being priced as a quality compounder. That makes this a story where the downside is mostly “multiple compression on uncertainty,” while the upside is “earnings rerating plus project de-risking.”

Contrarian view: the revenue miss matters less than the street is implying because the business may be transitioning from a volume narrative to a spread-and-credit narrative. If investors continue to anchor on sales growth, the setup could create an attractive entry window ahead of the next regulatory milestone. The real question is whether the market will pay up for repeatability of cash generation rather than scale, and in this cycle that may be the more important metric.

Key Decisions for Investors

• Go long REX on pullbacks over the next 1-2 weeks; upside is a rerating if the market re-focuses on cash generation and project de-risking, while downside is limited by the strong balance sheet and no bank debt.
• Use a call spread in REX for 3-6 months out rather than outright equity; the thesis is event-driven revaluation into the permitting milestone and expansion progress, with defined premium at risk.
• Pair long REX / short a less-capitalized ethanol peer basket for 1-2 quarters; thesis is that policy credits and project execution will widen the gap between funded incumbents and weaker operators.
• If holding the stock, hedge near-term policy risk with downside puts into the Illinois permitting date; the main left-tail is a regulatory delay that could compress the multiple before fundamentals roll over.
• Monitor for confirmation in Q2 margins rather than revenue; if gross profit stays elevated despite flat sales, add on weakness because that would validate the spread-driven earnings model.